Chapter 8. Adjuvant Radiotherapy and Chemoradiotherapy in the Treatment of Rectal Cancer
- John H. Scholefield1,
- Axel Grothey2,
- Herand Abcarian3 and
- Tim Maughan4
Published Online: 14 JAN 2008
Copyright © 2006 by Blackwell Publishing Ltd
Challenges in Colorectal Cancer
How to Cite
Cooper, R. and Sebag-Montefiore, D. (2006) Adjuvant Radiotherapy and Chemoradiotherapy in the Treatment of Rectal Cancer, in Challenges in Colorectal Cancer (eds J. H. Scholefield, A. Grothey, H. Abcarian and T. Maughan), Blackwell Publishing Ltd, Malden, Massachusetts, USA. doi: 10.1002/9780470753231.ch8
Professor of Surgery, University Hospital, Nottingham, UK
Professor, Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA
Turi Josefsen Professor and Chairman, Department of Surgery, University of Illinois College of Medicine, Chicago, Illinois, USA
Professor of Cancer Studies, University of Cardiff, Cardiff, UK
- Published Online: 14 JAN 2008
- Published Print: 1 JAN 2006
Print ISBN: 9781405127066
Online ISBN: 9780470753231
- rectal cancer;
This chapter contains section titled:
What is the evidence base for adjuvant radiotherapy?
What is the benefit of adjuvant radiotherapy in addition to total mesorectal excision surgery?
Is preoperative radiotherapy superior to postoperative radiotherapy?
What is the benefit of the addition of chemotherapy to long-course radiotherapy?
What is the evidence for the role of pelvic MRI in preoperative staging?
What are the late effects of adjuvant radiotherapy?
Why do international differences in selection policy in patients with resectable rectal cancer persist?
Preoperative chemoradiotherapy for locally advanced rectal cancer
Can adjuvant treatment achieve sphincter preservation?